A citation-based method for searching scientific literature


List of co-cited articles
285 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Action of C-type natriuretic peptide in isolated canine arteries and veins.
C M Wei, L L Aarhus, V M Miller, J C Burnett. Am J Physiol 1993
137
55

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
S Suga, K Nakao, K Hosoda, M Mukoyama, Y Ogawa, G Shirakami, H Arai, Y Saito, Y Kambayashi, K Inouye. Endocrinology 1992
652
28

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
932
28

Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).
K J Koller, D G Lowe, G L Bennett, N Minamino, K Kangawa, H Matsuo, D V Goeddel. Science 1991
712
23

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
A J Stingo, A L Clavell, D M Heublein, C M Wei, M R Pittelkow, J C Burnett. Am J Physiol 1992
236
23


Cardiovascular and renal actions of C-type natriuretic peptide.
A J Stingo, A L Clavell, L L Aarhus, J C Burnett. Am J Physiol 1992
158
23

C-type natriuretic peptide: a selective cardiovascular peptide.
A L Clavell, A J Stingo, C M Wei, D M Heublein, J C Burnett. Am J Physiol 1993
131
21

Bioactivity and metabolism of C-type natriuretic peptide in normal man.
P J Hunt, A M Richards, E A Espiner, M G Nicholls, T G Yandle. J Clin Endocrinol Metab 1994
142
16

C-type natriuretic peptide (CNP) in rats and humans.
Y Komatsu, K Nakao, S Suga, Y Ogawa, M Mukoyama, H Arai, G Shirakami, K Hosoda, O Nakagawa, N Hama. Endocrinology 1991
306
14



Atrial natriuretic peptide elevation in congestive heart failure in the human.
J C Burnett, P C Kao, D C Hu, D W Heser, D Heublein, J P Granger, T J Opgenorth, G S Reeder. Science 1986
909
12


C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells.
M Furuya, M Yoshida, Y Hayashi, N Ohnuma, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1991
183
12

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
R J Cody, S A Atlas, J H Laragh, S H Kubo, A B Covit, K S Ryman, A Shaknovich, K Pondolfino, M Clark, M J Camargo. J Clin Invest 1986
773
10

C-type natriuretic peptide inhibits intimal thickening after vascular injury.
M Furuya, K Aisaka, T Miyazaki, N Honbou, K Kawashima, T Ohno, S Tanaka, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1993
101
10

A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor.
M Chinkers, D L Garbers, M S Chang, D G Lowe, H M Chin, D V Goeddel, S Schulz. Nature 1989
10




Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
665
10

Renal actions of synthetic dendroaspis natriuretic peptide.
O Lisy, M Jougasaki, D M Heublein, J A Schirger, H H Chen, P W Wennberg, J C Burnett. Kidney Int 1999
82
10

Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Ondrej Lisy, Brenda K Huntley, Daniel J McCormick, Paul A Kurlansky, John C Burnett. J Am Coll Cardiol 2008
126
10


Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
C M Wei, C H Kim, V M Miller, J C Burnett. J Clin Invest 1993
53
9


Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep.
C J Charles, E A Espiner, A M Richards, M G Nicholls, T G Yandle. Am J Physiol 1995
31
16

Platelet-derived growth factor receptor signals.
L Claesson-Welsh. J Biol Chem 1994
476
8

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
8


Natriuretic peptide system in human heart failure.
C M Wei, D M Heublein, M A Perrella, A Lerman, R J Rodeheffer, C G McGregor, W D Edwards, H V Schaff, J C Burnett. Circulation 1993
362
8



Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
Jonathan D Sackner-Bernstein, Hal A Skopicki, Keith D Aaronson. Circulation 2005
544
8


Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.
N Hama, H Itoh, G Shirakami, S Suga, Y Komatsu, T Yoshimasa, I Tanaka, K Mori, K Nakao. Biochem Biophys Res Commun 1994
121
8

Diverse biological actions of atrial natriuretic peptide.
B M Brenner, B J Ballermann, M E Gunning, M L Zeidel. Physiol Rev 1990
882
8

Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure.
J A Schirger, D M Heublein, H H Chen, O Lisy, M Jougasaki, P W Wennberg, J C Burnett. Mayo Clin Proc 1999
89
7


C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure.
R I Cargill, C S Barr, W J Coutie, A D Struthers, B J Lipworth. Thorax 1994
38
10

Clearance function of type C receptors of atrial natriuretic factor in rats.
F A Almeida, M Suzuki, R M Scarborough, J A Lewicki, T Maack. Am J Physiol 1989
191
7

A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
7

Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor.
Sharmila D Chauhan, Holger Nilsson, Amrita Ahluwalia, Adrian J Hobbs. Proc Natl Acad Sci U S A 2003
187
7

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
Johannes-Peter Stasch, Peter Schmidt, Cristina Alonso-Alija, Heiner Apeler, Klaus Dembowsky, Michael Haerter, Markus Heil, Torsten Minuth, Elisabeth Perzborn, Ulrich Pleiss,[...]. Br J Pharmacol 2002
235
7

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa. J Am Coll Cardiol 2005
129
7

Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy.
Mitsuru Suwa, Yoshihiko Seino, Yoshikata Nomachi, Shinsuke Matsuki, Kazuteru Funahashi. Circ J 2005
91
7

The renal urodilatin system: clinical implications.
W Forssmann, M Meyer, K Forssmann. Cardiovasc Res 2001
65
7

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.
Oleg V Evgenov, Pál Pacher, Peter M Schmidt, György Haskó, Harald H H W Schmidt, Johannes-Peter Stasch. Nat Rev Drug Discov 2006
493
7

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
Johannes-Peter Stasch, Peter M Schmidt, Pavel I Nedvetsky, Tatiana Y Nedvetskaya, Arun Kumar H S, Sabine Meurer, Martin Deile, Ashraf Taye, Andreas Knorr, Harald Lapp,[...]. J Clin Invest 2006
322
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.